This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Oct;7(10).

doi: 10.1038/nrclinonc.2010.40-c1.

Alemtuzumab treatment for hemophagocytic lymphohistiocytosis

Maciej Machaczka, Johan Vaktnäs, Samuel C C Chiang, Yenan T Bryceson

PMID: 21080519
DOI: 10.1038/nrclinonc.2010.40-c1

Comment

Alemtuzumab treatment for hemophagocytic lymphohistiocytosis

Maciej Machaczka et al. Nat Rev Clin Oncol. 2010 Oct.

. 2010 Oct;7(10).

doi: 10.1038/nrclinonc.2010.40-c1.

Authors

Maciej Machaczka, Johan Vaktnäs, Samuel C C Chiang, Yenan T Bryceson

PMID: 21080519
DOI: 10.1038/nrclinonc.2010.40-c1

No abstract available

PubMed Disclaimer

Comment on

Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.
Strout MP, Seropian S, Berliner N. Strout MP, et al. Nat Rev Clin Oncol. 2010 Jul;7(7):415-20. doi: 10.1038/nrclinonc.2010.40. Epub 2010 Apr 20. Nat Rev Clin Oncol. 2010. PMID: 20404855

Similar articles

Fever, shock, and pancytopenia in a patient treated with alemtuzumab.
Bauer MP, van Burgel ND, Marijt WA, van Dissel JT, von dem Borne PA. Bauer MP, et al. Clin Infect Dis. 2009 Nov 15;49(10):1540; 1616-7. doi: 10.1086/644730. Clin Infect Dis. 2009. PMID: 19857167 No abstract available.
Alemtuzumab.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2001 Dec 15;58(24):2372-3. doi: 10.1093/ajhp/58.24.2372. Am J Health Syst Pharm. 2001. PMID: 11794950 No abstract available.
Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.
Strout MP, Seropian S, Berliner N. Strout MP, et al. Nat Rev Clin Oncol. 2010 Jul;7(7):415-20. doi: 10.1038/nrclinonc.2010.40. Epub 2010 Apr 20. Nat Rev Clin Oncol. 2010. PMID: 20404855
Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemia.
Osterborg A, Mellstedt H, Keating M. Osterborg A, et al. Med Oncol. 2002;19 Suppl:S21-6. doi: 10.1385/mo:19:2s:s21. Med Oncol. 2002. PMID: 12180488 Review.
Alemtuzumab.
Ravandi F, O'Brien S. Ravandi F, et al. Expert Rev Anticancer Ther. 2005 Feb;5(1):39-51. doi: 10.1586/14737140.5.1.39. Expert Rev Anticancer Ther. 2005. PMID: 15757437 Review.

See all similar articles

Cited by

Hemophagocytic lymphohistiocytosis: review of etiologies and management.
George MR. George MR. J Blood Med. 2014 Jun 12;5:69-86. doi: 10.2147/JBM.S46255. eCollection 2014. J Blood Med. 2014. PMID: 24966707 Free PMC article. Review.
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy.
Hughes AD, Teachey DT, Diorio C. Hughes AD, et al. Semin Immunopathol. 2024 Jul 16;46(3-4):5. doi: 10.1007/s00281-024-01013-w. Semin Immunopathol. 2024. PMID: 39012374 Free PMC article. Review.
Hemophagocytic Lymphohistiocytosis in the Setting of Progressive Chronic Lymphocytic Leukemia With Five Concurrent Life-Threatening Infections.
Patel H, Patresan J, Krzywicki V, Ramirez Gamero A, Colvin G. Patel H, et al. Cureus. 2025 Apr 29;17(4):e83209. doi: 10.7759/cureus.83209. eCollection 2025 Apr. Cureus. 2025. PMID: 40443618 Free PMC article.
Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.
Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, Ehl S. Bode SF, et al. Arthritis Res Ther. 2012 Jun 8;14(3):213. doi: 10.1186/ar3843. Arthritis Res Ther. 2012. PMID: 22682420 Free PMC article. Review.
Hemophagocytic syndrome in children and adults.
Malinowska I, Machaczka M, Popko K, Siwicka A, Salamonowicz M, Nasiłowska-Adamska B. Malinowska I, et al. Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):385-94. doi: 10.1007/s00005-014-0274-1. Epub 2014 Feb 9. Arch Immunol Ther Exp (Warsz). 2014. PMID: 24509696 Free PMC article. Review.

References

1. Nat Rev Clin Oncol. 2010 Jul;7(7):415-20 - PubMed
1. Int J Hematol. 2007 Jul;86(1):58-65 - PubMed
1. Cancer. 2009 Sep 1;115(17):3830-41 - PubMed
1. Pediatr Blood Cancer. 2007 Feb;48(2):124-31 - PubMed
1. Haematologica. 2008 Feb;93(2):291-4 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.